Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Radial artery-first dorsal metacarpal vein arteriovenous fistula in the first interdigital space of the dorsal hand for hemodialysis.

Takashima T, Nakashima Y, Suenaga A, Yamashita Y, Nonaka Y, Fukuda M, Rikitake S, Miyazono M, Rikitake K, Ikeda Y.

J Vasc Access. 2019 Nov 5:1129729819884477. doi: 10.1177/1129729819884477. [Epub ahead of print]

PMID:
31686621
2.

Scrotal angiomyxoma.

Koito R, Kohda F, Dugu L, Suenaga A, Ichiki T, Furue M.

Australas J Dermatol. 2020 Feb;61(1):78-79. doi: 10.1111/ajd.13158. Epub 2019 Sep 10. No abstract available.

PMID:
31506929
3.

Effects of hydrogen-rich water in a rat model of polycystic kidney disease.

Yamasaki M, Miyazono M, Yoshihara M, Suenaga A, Mizuta M, Fukuda M, Rikitake S, Ikeda Y.

PLoS One. 2019 Apr 23;14(4):e0215766. doi: 10.1371/journal.pone.0215766. eCollection 2019.

4.

Clinical Condition and Management of 114 Mamushi (Gloydius blomhoffii) Bites in a General Hospital in Japan.

Chiba T, Koga H, Kimura N, Murata M, Jinnai S, Suenaga A, Kohda F, Furue M.

Intern Med. 2018 Apr 15;57(8):1075-1080. doi: 10.2169/internalmedicine.9409-17. Epub 2017 Dec 27.

5.

Immunohistological Localization of Peroxisome Proliferator-Activated Receptor α and γ in Human Sebaceous Glands.

Furue M, Takemura M, Nishio K, Sato Y, Nagata S, Kan N, Suenaga A, Furue K, Yoshida M, Konishi S, Tsuji G.

Fukuoka Igaku Zasshi. 2016 Nov;107(11):199-203.

PMID:
29227070
6.

Tissue alkalosis in cold-ischemia time.

Denninghoff V, Olivieri EHR, Fresno C, Uceda A, Mota L, Suenaga AP, Carraro DM, Martins VR, Avagnina A, Soares FA, Campos AHJFM.

Sci Rep. 2017 Sep 7;7(1):10867. doi: 10.1038/s41598-017-11284-z.

7.

Functional profiling of asymmetrically-organized human CCT/TRiC chaperonin.

Araki K, Suenaga A, Kusano H, Tanaka R, Hatta T, Natsume T, Fukui K.

Biochem Biophys Res Commun. 2016 Dec 9;481(3-4):232-238. doi: 10.1016/j.bbrc.2016.10.120. Epub 2016 Oct 30.

PMID:
27806916
8.

Evaluation of protein-ligand affinity prediction using steered molecular dynamics simulations.

Okimoto N, Suenaga A, Taiji M.

J Biomol Struct Dyn. 2017 Nov;35(15):3221-3231. doi: 10.1080/07391102.2016.1251851. Epub 2016 Nov 7.

PMID:
27771988
9.

Protective Effect of Dimethyl Fumarate on an Oxidative Stress Model Induced by Sodium Nitroprusside in Mice.

Kume T, Suenaga A, Izumi Y, Akaike A.

Biol Pharm Bull. 2016;39(6):1055-9. doi: 10.1248/bpb.b16-00134.

10.

All-atom molecular dynamics analysis of multi-peptide systems reproduces peptide solubility in line with experimental observations.

Kuroda Y, Suenaga A, Sato Y, Kosuda S, Taiji M.

Sci Rep. 2016 Jan 28;6:19479. doi: 10.1038/srep19479.

11.

Tuning of poly-S-nitrosated human serum albumin as superior antitumor nanomedicine.

Ishima Y, Fang J, Kragh-Hansen U, Yin H, Liao L, Katayama N, Watanabe H, Kai T, Suenaga A, Maeda H, Otagiri M, Maruyama T.

J Pharm Sci. 2014 Jul;103(7):2184-2188. doi: 10.1002/jps.24020. Epub 2014 May 20.

PMID:
24846171
12.

Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses.

Miura T, Sano D, Suenaga A, Yoshimura T, Fuzawa M, Nakagomi T, Nakagomi O, Okabe S.

J Virol. 2013 Sep;87(17):9441-51. doi: 10.1128/JVI.01060-13. Epub 2013 Jun 26.

13.

Ligand Diffusion on Protein Surface Observed in Molecular Dynamics Simulation.

Nerukh D, Okimoto N, Suenaga A, Taiji M.

J Phys Chem Lett. 2012 Dec 6;3(23):3476-9. doi: 10.1021/jz301635h. Epub 2012 Nov 14.

PMID:
26290975
14.

Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models.

Ishima Y, Hara M, Kragh-Hansen U, Inoue A, Suenaga A, Kai T, Watanabe H, Otagiri M, Maruyama T.

J Control Release. 2012 Nov 28;164(1):1-7. doi: 10.1016/j.jconrel.2012.10.003. Epub 2012 Oct 11.

PMID:
23063551
15.

S-nitrosated α-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis.

Watanabe K, Ishima Y, Akaike T, Sawa T, Kuroda T, Ogawa W, Watanabe H, Suenaga A, Kai T, Otagiri M, Maruyama T.

FASEB J. 2013 Jan;27(1):391-8. doi: 10.1096/fj.12-217794. Epub 2012 Oct 9.

PMID:
23047897
16.

Experimental identification and theoretical analysis of a thermally stabilized green fluorescent protein variant.

Akiyama S, Suenaga A, Kobayashi T, Kamioka T, Taiji M, Kuroda Y.

Biochemistry. 2012 Oct 9;51(40):7974-82. doi: 10.1021/bi300580j. Epub 2012 Sep 27.

PMID:
22963334
17.

An efficient computational method for calculating ligand binding affinities.

Suenaga A, Okimoto N, Hirano Y, Fukui K.

PLoS One. 2012;7(8):e42846. doi: 10.1371/journal.pone.0042846. Epub 2012 Aug 20.

18.

Arginine 485 of human serum albumin interacts with the benzophenone moiety of ketoprofen in the binding pocket of subdomain III A and III B.

Kaneko K, Chuang VT, Ito T, Suenaga A, Watanabe H, Maruyama T, Otagiri M.

Pharmazie. 2012 May;67(5):414-8.

PMID:
22764574
19.

Calculating the Na⁺ translocating V-ATPase catalytic site affinity for substrate binding by homology modeled NtpA monomer using molecular dynamics/free energy calculation.

Muhammed Z, Arai S, Saijo S, Yamato I, Murata T, Suenaga A.

J Mol Graph Model. 2012 Jul;37:59-66. doi: 10.1016/j.jmgm.2012.03.006. Epub 2012 Mar 30.

PMID:
22622011
20.

Blockade of inflammatory responses by a small-molecule inhibitor of the Rac activator DOCK2.

Nishikimi A, Uruno T, Duan X, Cao Q, Okamura Y, Saitoh T, Saito N, Sakaoka S, Du Y, Suenaga A, Kukimoto-Niino M, Miyano K, Gotoh K, Okabe T, Sanematsu F, Tanaka Y, Sumimoto H, Honma T, Yokoyama S, Nagano T, Kohda D, Kanai M, Fukui Y.

Chem Biol. 2012 Apr 20;19(4):488-97. doi: 10.1016/j.chembiol.2012.03.008.

21.

Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutants.

Iwao Y, Ishima Y, Yamada J, Noguchi T, Kragh-Hansen U, Mera K, Honda D, Suenaga A, Maruyama T, Otagiri M.

IUBMB Life. 2012 May;64(5):450-4. doi: 10.1002/iub.567. Epub 2012 Feb 20.

22.

Characterization of hepatic cellular uptake of α1-acid glycoprotein (AGP), part 2: involvement of hemoglobin β-chain on plasma membranes in the uptake of human AGP by liver parenchymal cells.

Komori H, Nishi K, Uehara N, Watanabe H, Shuto T, Suenaga A, Maruyama T, Otagiri M.

J Pharm Sci. 2012 Apr;101(4):1607-15. doi: 10.1002/jps.23015. Epub 2012 Jan 6.

PMID:
22227718
23.

Characterization of the hepatic cellular uptake of α(1) -acid glycoprotein (AGP), part 1: a peptide moiety of human AGP is recognized by the hemoglobin β-chain on mouse liver parenchymal cells.

Nishi K, Komori H, Kikuchi M, Uehara N, Fukunaga N, Matsumoto K, Watanabe H, Nakajou K, Misumi S, Suenaga A, Maruyama T, Otagiri M.

J Pharm Sci. 2012 Apr;101(4):1599-606. doi: 10.1002/jps.22804. Epub 2011 Nov 11.

PMID:
22081433
24.

Toxicodynamic evaluation of a cisplatin-chondroitin sulfate complex using a perfused kidney and human proximal tubular cells.

Zhang JS, Kadowaki D, Nonoguchi H, Hirata S, Seo H, Imai T, Suenaga A, Giam Chuang VT, Otagiri M.

Ren Fail. 2011;33(6):609-14. doi: 10.3109/0886022X.2011.585266. Epub 2011 Jun 1.

PMID:
21631182
25.

Quantitative analysis of cysteine-34 on the anitioxidative properties of human serum albumin in hemodialysis patients.

Anraku M, Takeuchi K, Watanabe H, Kadowaki D, Kitamura K, Tomita K, Kuniyasu A, Suenaga A, Maruyama T, Otagiri M.

J Pharm Sci. 2011 Sep;100(9):3968-76. doi: 10.1002/jps.22571. Epub 2011 Apr 7.

PMID:
21480235
26.

Structural insights into differences in drug-binding selectivity between two forms of human alpha1-acid glycoprotein genetic variants, the A and F1*S forms.

Nishi K, Ono T, Nakamura T, Fukunaga N, Izumi M, Watanabe H, Suenaga A, Maruyama T, Yamagata Y, Curry S, Otagiri M.

J Biol Chem. 2011 Apr 22;286(16):14427-34. doi: 10.1074/jbc.M110.208926. Epub 2011 Feb 24.

27.

Spectroscopic studies of interactions of chondroitin sulfates with cisplatin.

Zhang JS, Anraku M, Kadowaki D, Imai T, Suenaga A, Odani A, Otagiri M.

Carbohydr Res. 2011 Apr 1;346(5):631-7. doi: 10.1016/j.carres.2011.01.007. Epub 2011 Jan 15.

PMID:
21324437
28.

Distribution and species composition of juvenile and adult scombropids (Teleostei, Scombropidae) in Japanese coastal waters.

Itoi S, Odaka J, Yuasa K, Akeno S, Nakajima A, Suenaga A, Noda T, Akimoto S, Myojin T, Ikeda Y, Masuda Y, Takai N, Yoshihara K, Sugita H.

J Fish Biol. 2010 Feb;76(2):369-78. doi: 10.1111/j.1095-8649.2009.02493.x.

PMID:
20738713
29.

Construction of an expression system for human alpha(1)-acid glycoprotein in E. coli: The roles of oligosaccharide moieties in structural and functional properties.

Nishi K, Fukunaga N, Ono T, Akuta T, Yumita N, Watanabe H, Kadowaki D, Suenaga A, Maruyama T, Otagiri M.

Drug Metab Pharmacokinet. 2010;25(2):200-7.

30.

Receptor-mediated uptake of human alpha1-acid glycoprotein into liver parenchymal cells in mice.

Matsumoto K, Nishi K, Kikuchi M, Watanabe H, Nakajou K, Komori H, Kadowaki D, Suenaga A, Maruyama T, Otagiri M.

Drug Metab Pharmacokinet. 2010;25(1):101-7.

31.
32.

Reversible hydrogel formation driven by protein-peptide-specific interaction and chondrocyte entrapment.

Ito F, Usui K, Kawahara D, Suenaga A, Maki T, Kidoaki S, Suzuki H, Taiji M, Itoh M, Hayashizaki Y, Matsuda T.

Biomaterials. 2010 Jan;31(1):58-66. doi: 10.1016/j.biomaterials.2009.09.026. Epub 2009 Oct 17.

PMID:
19836832
33.

Nitrosylated human serum albumin (SNO-HSA) induces apoptosis in tumor cells.

Katayama N, Nakajou K, Ishima Y, Ikuta S, Yokoe J, Yoshida F, Suenaga A, Maruyama T, Kai T, Otagiri M.

Nitric Oxide. 2010 May 15;22(4):259-65. doi: 10.1016/j.niox.2009.09.003. Epub 2009 Oct 8.

PMID:
19818866
34.

High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations.

Okimoto N, Futatsugi N, Fuji H, Suenaga A, Morimoto G, Yanai R, Ohno Y, Narumi T, Taiji M.

PLoS Comput Biol. 2009 Oct;5(10):e1000528. doi: 10.1371/journal.pcbi.1000528. Epub 2009 Oct 9.

35.

Mutation of epidermal growth factor receptor is associated with MIG6 expression.

Nagashima T, Ushikoshi-Nakayama R, Suenaga A, Ide K, Yumoto N, Naruo Y, Takahashi K, Saeki Y, Taiji M, Tanaka H, Tsai SF, Hatakeyama M.

FEBS J. 2009 Sep;276(18):5239-51. doi: 10.1111/j.1742-4658.2009.07220.x. Epub 2009 Aug 10.

36.

Nanoscale elongating control of the self-assembled protein filament with the cysteine-introduced building blocks.

Usui K, Maki T, Ito F, Suenaga A, Kidoaki S, Itoh M, Taiji M, Matsuda T, Hayashizaki Y, Suzuki H.

Protein Sci. 2009 May;18(5):960-9. doi: 10.1002/pro.106. Erratum in: Protein Sci. 2009 Jul;18(7):1571.

37.

Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop.

Seo JH, Suenaga A, Hatakeyama M, Taiji M, Imamoto A.

Mol Cell Biol. 2009 Jun;29(11):3076-87. doi: 10.1128/MCB.01686-08. Epub 2009 Mar 23.

38.

Molecular dynamics simulations reveal that Tyr-317 phosphorylation reduces Shc binding affinity for phosphotyrosyl residues of epidermal growth factor receptor.

Suenaga A, Hatakeyama M, Kiyatkin AB, Radhakrishnan R, Taiji M, Kholodenko BN.

Biophys J. 2009 Mar 18;96(6):2278-88. doi: 10.1016/j.bpj.2008.11.018.

39.

A site-directed mutagenesis study of drug-binding selectivity in genetic variants of human alpha(1)-acid glycoprotein.

Nishi K, Ueno M, Murakami Y, Fukunaga N, Akuta T, Kadowaki D, Watanabe H, Suenaga A, Maruyama T, Otagiri M.

J Pharm Sci. 2009 Nov;98(11):4316-26. doi: 10.1002/jps.21697.

PMID:
19198000
40.

Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin.

Iwao Y, Hiraike M, Kragh-Hansen U, Kawai K, Suenaga A, Maruyama T, Otagiri M.

Biochim Biophys Acta. 2009 Apr;1794(4):634-41. doi: 10.1016/j.bbapap.2008.11.022. Epub 2008 Dec 8.

PMID:
19110077
41.

S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding.

Ishima Y, Akaike T, Kragh-Hansen U, Hiroyama S, Sawa T, Suenaga A, Maruyama T, Kai T, Otagiri M.

J Biol Chem. 2008 Dec 12;283(50):34966-75. doi: 10.1074/jbc.M807009200. Epub 2008 Oct 20.

42.

Structural basis for multimeric heme complexation through a specific protein-heme interaction: the case of the third neat domain of IsdH from Staphylococcus aureus.

Watanabe M, Tanaka Y, Suenaga A, Kuroda M, Yao M, Watanabe N, Arisaka F, Ohta T, Tanaka I, Tsumoto K.

J Biol Chem. 2008 Oct 17;283(42):28649-59. doi: 10.1074/jbc.M803383200. Epub 2008 Jul 30.

43.

Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface.

Kosa T, Nishi K, Maruyama T, Sakai N, Yonemura N, Watanabe H, Suenaga A, Otagiri M.

J Pharm Sci. 2007 Nov;96(11):3117-24.

PMID:
17979211
44.

Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin.

Kaneko K, Fukuda H, Chuang VT, Yamasaki K, Kawahara K, Nakayama H, Suenaga A, Maruyama T, Otagiri M.

Drug Metab Dispos. 2008 Jan;36(1):81-6. Epub 2007 Oct 9.

PMID:
17925384
45.

Alpha1-acid glycoprotein suppresses rat acute inflammatory paw edema through the inhibition of neutrophils activation and prostaglandin E2 generation.

Matsumoto K, Nishi K, Kikuchi M, Kadowaki D, Tokutomi Y, Tokutomi N, Nishi K, Suenaga A, Otagiri M.

Biol Pharm Bull. 2007 Jul;30(7):1226-30.

46.

Folding dynamics of 10-residue beta-hairpin peptide chignolin.

Suenaga A, Narumi T, Futatsugi N, Yanai R, Ohno Y, Okimoto N, Taiji M.

Chem Asian J. 2007 May 4;2(5):591-8.

PMID:
17465405
47.

Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency.

Kurokawa K, Yorifuji T, Kawai M, Momoi T, Nagasaka H, Takayanagi M, Kobayashi K, Yoshino M, Kosho T, Adachi M, Otsuka H, Yamamoto S, Murata T, Suenaga A, Ishii T, Terada K, Shimura N, Kiwaki K, Shintaku H, Yamakawa M, Nakabayashi H, Wakutani Y, Nakahata T.

J Hum Genet. 2007;52(4):349-354. doi: 10.1007/s10038-007-0122-9. Epub 2007 Feb 20.

PMID:
17310273
48.

Crystal structure of the rac activator, Asef, reveals its autoinhibitory mechanism.

Murayama K, Shirouzu M, Kawasaki Y, Kato-Murayama M, Hanawa-Suetsugu K, Sakamoto A, Katsura Y, Suenaga A, Toyama M, Terada T, Taiji M, Akiyama T, Yokoyama S.

J Biol Chem. 2007 Feb 16;282(7):4238-42. Epub 2006 Dec 26.

49.

[A case of Mycobacterium fortuitum meningitis following surgery for meningioma].

Fujikawa K, Suenaga A, Motomura M, Fukuda T, Ooe N, Eguchi K.

Rinsho Shinkeigaku. 2006 Jul;46(7):480-4. Japanese.

PMID:
17061701
50.

Inhibition of eukaryotic translation initiation factor 5A (eIF5A) hypusination impairs melanoma growth.

Jasiulionis MG, Luchessi AD, Moreira AG, Souza PP, Suenaga AP, Correa M, Costa CA, Curi R, Costa-Neto CM.

Cell Biochem Funct. 2007 Jan-Feb;25(1):109-14.

PMID:
16850525

Supplemental Content

Loading ...
Support Center